IO Biotech Inc
NASDAQ:IOBT
Income Statement
Earnings Waterfall
IO Biotech Inc
Revenue
|
0
USD
|
Operating Expenses
|
-91.4m
USD
|
Operating Income
|
-91.4m
USD
|
Other Expenses
|
5.4m
USD
|
Net Income
|
-86.1m
USD
|
Income Statement
IO Biotech Inc
Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||
Operating Expenses |
(41)
|
(45)
|
(64)
|
(72)
|
(71)
|
(72)
|
(76)
|
(84)
|
(91)
|
|
Selling, General & Administrative |
(11)
|
(15)
|
(21)
|
(23)
|
(24)
|
(24)
|
(23)
|
(23)
|
(24)
|
|
Research & Development |
(30)
|
(31)
|
(43)
|
(49)
|
(47)
|
(49)
|
(53)
|
(60)
|
(68)
|
|
Operating Income |
(41)
N/A
|
(45)
-10%
|
(64)
-40%
|
(72)
-14%
|
(71)
+1%
|
(72)
-1%
|
(76)
-5%
|
(84)
-10%
|
(91)
-9%
|
|
Pre-Tax Income | ||||||||||
Interest Income Expense |
(0)
|
(0)
|
(1)
|
(0)
|
1
|
3
|
4
|
5
|
6
|
|
Total Other Income |
(27)
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(68)
N/A
|
(43)
+37%
|
(61)
-43%
|
(72)
-18%
|
(70)
+3%
|
(70)
+1%
|
(72)
-3%
|
(78)
-9%
|
(85)
-9%
|
|
Net Income | ||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
|
Income from Continuing Operations |
(68)
|
(43)
|
(61)
|
(73)
|
(71)
|
(71)
|
(74)
|
(80)
|
(86)
|
|
Net Income (Common) |
(75)
N/A
|
(46)
+38%
|
(65)
-40%
|
(74)
-14%
|
(71)
+3%
|
(71)
+0%
|
(74)
-4%
|
(80)
-8%
|
(86)
-8%
|
|
EPS (Diluted) |
-2.6
N/A
|
-1.6
+38%
|
-2.24
-40%
|
-2.56
-14%
|
-2.48
+3%
|
-2.47
+0%
|
-2.56
-4%
|
-1.59
+38%
|
-1.98
-25%
|